CYPB - Cypress BioScience Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYPB - Cypress BioScience

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jay Lowe who wrote (274)	6/3/1998 11:55:00 AM
From: dwight martin	Read Replies (1) of 586

Yeah, I'm also curious about the claimed virtue of the column in "severe, drug-resistant cases." While I am not known for medical knowledge, it seems to me that if the less-severe manifestation of the disease is caused in whole or part by the same circulating factors causing the severe form, the column's clearing action should also work in those less severe cases. And the column treatment lasts for a long time, with no side effects . . . ? What is the general thread sentiment on the reverse split and its likely effect on stock price this summer?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next